Reviewed by Peptide Treatments Medical Advisory Board (Medical Advisory Board)
CagriSema: Contraindications & Drug Interactions
Safety information for CagriSema including known contraindications, drug interactions, and important precautions.
Back to CagriSema overviewContraindications
- personal or family history of medullary thyroid carcinoma (MTC)
- multiple endocrine neoplasia syndrome type 2 (MEN 2)
- history of pancreatitis
- pregnancy
Drug Interactions (4 interactions)
Important: This table summarizes known and theoretical interactions. Always consult a healthcare provider before combining CagriSema with any medication.
| Drug | Classification | Mechanism |
|---|---|---|
| Other GLP-1 agonists | Contraindicated | Duplicative GLP-1 receptor agonism — do not combine |
| Pramlintide (amylin analogs) | Contraindicated | Duplicative amylin receptor agonism — increased amylin effect |
| Insulin | Documented | Increased hypoglycemia risk — reduce insulin dose by 20% |
| Sulfonylureas | Documented | Increased hypoglycemia risk — reduce sulfonylurea dose by 50% |
Use our interactive Drug Interaction Checker for real-time lookup.